20.648 articles found

[Transcutaneous auricular vagus nerve stimulation in treatment of primary Parkinson's disease: a randomized, controlled, single-blind trial].

Yu Z, Zhou Z, Zheng C, Su Q, Hou X, Luo X, Liu Z, Lan X, Wang L, Li Z.

Zhongguo Zhen Jiu · 2025-12-02

DOI: 10.13703/j.0255-2930.20241116-0002PMID: 41741977

Did You Care for the Orchids This Week? Outcomes of Person-Centered Cognitive Therapy for Parkinson’s Disease

Check source for author details

Innovation in aging · 2025-12-01

Decoding the therapeutic potential mechanism of <i>Cornus officinalis</i> in Parkinson's disease: a network pharmacology insight.

Wu Z, Zhao J, Wang W, Dong Y, Zhou T, Feng Y, Deng Y, Feng Y.

Front Pharmacol · 2025-12-01

DOI: 10.3389/fphar.2025.1714796PMID: 41403435

Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review.

Bhamare UU, Talpade A, Pingili RB, Palkar MB.

Eur J Neurosci · 2025-12-01

DOI: 10.1111/ejn.70343PMID: 41318966

A nanoMIP sensor for real-time in vivo monitoring of levodopa pharmacokinetics in precision Parkinson's therapy.

Zhou Y, Li J, Xu Z, Zhao Y, Zhang S, Liu T, Yao Y, Fang L, Cai Y, Ye X, Liang B.

Nat Commun · 2025-12-01

DOI: 10.1038/s41467-025-65853-2PMID: 41326343

Nanomaterials: an overview of current trends and future prospects in neurological disorder treatment.

Eshak D, Arumugam M.

J Transl Med · 2025-12-01

DOI: 10.1186/s12967-025-06877-6PMID: 41327179

Transient Receptor Potential Channels as Key Regulators of Neuroinflammation in Neurological Disorders: Mechanistic Insights, Therapeutic Potentials, and Future Directions.

Guo D, Cai M, Xian Y, Chen Y, Feng Y, Hu C, Zeng L, Shi L, Zhang S.

CNS Neurosci Ther · 2025-12-01

DOI: 10.1002/cns.70700PMID: 41399206

Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis.

Xie SS, Liu ZG.

World J Gastroenterol · 2025-12-01

DOI: 10.3748/wjg.v31.i46.113298PMID: 41479642

Targeting the <i>LRRK2 G2019S</i> Mutation Found in Parkinson's Disease: Efficiency of Biosynthesized Solid Lipid Nanoparticles for Therapeutic siRNA-Mediated Gene Therapy.

Jagaran K, Singh M.

Front Biosci (Elite Ed) · 2025-12-01

DOI: 10.31083/fbe44344PMID: 41504091

[Intractable Hemorrhagic Duodenal Ulcer after Atezolizumab plus Bevacizumab Treatment for Hepatic Cancer with Lymph Node Metastases-A Case Report].

Tsukamoto T, Nishiyama M, Kunimoto T, Kaizaki R, Fukushima H.

Gan To Kagaku Ryoho · 2025-12-01

PMID: 41546366

Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson's Disease: Post Hoc Analysis of a Randomized Trial.

Antonini A, Bergmans B, Kern DS, Gandor F, Nishikawa N, Standaert DG, Fritz B, Gupta R, Nozaki T, Shah MB, Bergmann L, Kimber T.

Neurol Ther · 2025-12-01

DOI: 10.1007/s40120-025-00856-1PMID: 41324738

Oxeiptosis in Parkinson's disease: Unraveling the KEAP1/PGAM5/AIFM1 Axis and its role in pathophysiology and therapeutics.

Rong Z, Liu T, Wei J.

Cell Signal · 2025-12-01

DOI: 10.1016/j.cellsig.2025.112288PMID: 41338468